{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:20:37Z","timestamp":1791584437589,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX24_3596"],"award-info":[{"award-number":["KYCX24_3596"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX23_0689"],"award-info":[{"award-number":["SJCX23_0689"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370777"],"award-info":[{"award-number":["82370777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72918-7","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:03:42Z","timestamp":1727431422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intratumoral microbiota as a novel prognostic indicator in bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"72918_CR1","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1097\/CM9.0000000000000871","volume":"133","author":"XB Qian","year":"2020","unstructured":"Qian, X. B. et al. A guide to human microbiome research: Study design, sample collection, and bioinformatics analysis. Chin. Med. J. (Engl.)133, 1844\u20131855. https:\/\/doi.org\/10.1097\/CM9.0000000000000871 (2020).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"72918_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Quevrain","year":"2016","unstructured":"Quevrain, E. et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut. 65, 415\u2013425. https:\/\/doi.org\/10.1136\/gutjnl-2014-307649 (2016).","journal-title":"Gut"},{"key":"72918_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7785","author":"MR Wilson","year":"2019","unstructured":"Wilson, M. R. et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science. https:\/\/doi.org\/10.1126\/science.aar7785 (2019).","journal-title":"Science"},{"key":"72918_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 357, 1156\u20131160. https:\/\/doi.org\/10.1126\/science.aah5043 (2017).","journal-title":"Science"},{"key":"72918_CR5","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel, R. J., Drewes, J. L. & Sears, C. L. The cancer microbiome: Recent highlights and knowledge gaps. Cancer Discov. 11, 2378\u20132395. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0324 (2021).","journal-title":"Cancer Discov"},{"key":"72918_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185, 1356\u20131372 e1326 (2022). https:\/\/doi.org\/10.1016\/j.cell.2022.02.027","journal-title":"Cell"},{"key":"72918_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fonc.2020.00179","volume":"10","author":"SP Walker","year":"2020","unstructured":"Walker, S. P., Tangney, M. & Claesson, M. J. Sequence-based characterization of intratumoral bacteria\u2014a guide to best practice. Front. Oncol.10, 179. https:\/\/doi.org\/10.3389\/fonc.2020.00179 (2020).","journal-title":"Front. Oncol."},{"key":"72918_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 42, 344\u2013355. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.010 (2015).","journal-title":"Immunity"},{"key":"72918_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 368, 973\u2013980. https:\/\/doi.org\/10.1126\/science.aay9189 (2020).","journal-title":"Science"},{"key":"72918_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2020.09.005","volume":"38","author":"E Allen-Vercoe","year":"2020","unstructured":"Allen-Vercoe, E., & Coburn, B. A microbiota-derived metabolite augments cancer immunotherapy responses in mice. Cancer Cell38, 452\u2013453. https:\/\/doi.org\/10.1016\/j.ccell.2020.09.005 (2020).","journal-title":"Cancer Cell"},{"key":"72918_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","volume":"5","author":"E Zagato","year":"2020","unstructured":"Zagato, E. et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat. Microbiol.5, 511\u2013524. https:\/\/doi.org\/10.1038\/s41564-019-0649-5 (2020).","journal-title":"Nat. Microbiol."},{"key":"72918_CR12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager, L. F. et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 369, 1481\u20131489. https:\/\/doi.org\/10.1126\/science.abc3421 (2020).","journal-title":"Science"},{"key":"72918_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178, 795\u2013806 e712 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.07.008","journal-title":"Cell"},{"key":"72918_CR14","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ijc.31011","volume":"141","author":"V Eklof","year":"2017","unstructured":"Eklof, V. et al. Cancer-associated fecal microbial markers in colorectal cancer detection. Int. J. Cancer. 141, 2528\u20132536. https:\/\/doi.org\/10.1002\/ijc.31011 (2017).","journal-title":"Int. J. Cancer"},{"key":"72918_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/CS20160876","volume":"131","author":"J Gagniere","year":"2017","unstructured":"Gagniere, J. et al. Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clin. Sci. (Lond.). 131, 471\u2013485. https:\/\/doi.org\/10.1042\/CS20160876 (2017).","journal-title":"Clin. Sci. (Lond.)"},{"key":"72918_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00262-020-02657-x","volume":"70","author":"JA Lee","year":"2021","unstructured":"Lee, J. A. et al. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status. Cancer Immunol. Immunother. 70, 47\u201359. https:\/\/doi.org\/10.1007\/s00262-020-02657-x (2021).","journal-title":"Cancer Immunol. Immunother"},{"key":"72918_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin.73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"72918_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9, 58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"72918_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10654-013-9851-6","volume":"28","author":"IT Gram","year":"2013","unstructured":"Gram, I. T., Sandin, S., Braaten, T., Lund, E. & Weiderpass, E. The hazards of death by smoking in middle-aged women. Eur. J. Epidemiol.28, 799\u2013806. https:\/\/doi.org\/10.1007\/s10654-013-9851-6 (2013).","journal-title":"Eur. J. Epidemiol."},{"key":"72918_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","volume":"68","author":"H Bi","year":"2019","unstructured":"Bi, H. et al. Urinary microbiota\u2014A potential biomarker and therapeutic target for bladder cancer. J. Med. Microbiol.68, 1471\u20131478. https:\/\/doi.org\/10.1099\/jmm.0.001058 (2019).","journal-title":"J. Med. Microbiol."},{"key":"72918_CR21","doi-asserted-by":"publisher","first-page":"D1205","DOI":"10.1093\/nar\/gkac891","volume":"51","author":"KP Chen","year":"2023","unstructured":"Chen, K. P., Hsu, C. L., Oyang, Y. J., Huang, H. C. & Juan, H. F. BIC: A database for the transcriptional landscape of bacteria in cancer. Nucleic Acids Res.51, D1205\u2013D1211. https:\/\/doi.org\/10.1093\/nar\/gkac891 (2023).","journal-title":"Nucleic Acids Res."},{"key":"72918_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","volume":"67","author":"W Li","year":"2022","unstructured":"Li, W. et al. Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. Cytokine Growth Factor. Rev.67, 49\u201357. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.07.004 (2022).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"72918_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res.28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"72918_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ajcnut.2022.11.020","volume":"117","author":"BA Peters","year":"2023","unstructured":"Peters, B. A. et al. Healthy dietary patterns are associated with the gut microbiome in the Hispanic Community Health Study\/Study of latinos. Am. J. Clin. Nutr.117, 540\u2013552. https:\/\/doi.org\/10.1016\/j.ajcnut.2022.11.020 (2023).","journal-title":"Am. J. Clin. Nutr."},{"key":"72918_CR25","doi-asserted-by":"publisher","first-page":"e14618","DOI":"10.1111\/ijcp.14618","volume":"75","author":"F Naeini","year":"2021","unstructured":"Naeini, F. et al. Spirulina supplementation as an adjuvant therapy in enhancement of antioxidant capacity: A systematic review and meta-analysis of controlled clinical trials. Int. J. Clin. Pract.75, e14618. https:\/\/doi.org\/10.1111\/ijcp.14618 (2021).","journal-title":"Int. J. Clin. Pract."},{"key":"72918_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/md19060293","author":"V Sorrenti","year":"2021","unstructured":"Sorrenti, V. et al. Spirulina microalgae and brain health: A scoping review of experimental and clinical evidence. Mar. Drugs. https:\/\/doi.org\/10.3390\/md19060293 (2021).","journal-title":"Mar. Drugs"},{"key":"72918_CR27","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.ctim.2019.102211","volume":"47","author":"S Moradi","year":"2019","unstructured":"Moradi, S. et al. Effects of Spirulina supplementation on obesity: A systematic review and meta-analysis of randomized clinical trials. Complement. Ther. Med.47, 102211. https:\/\/doi.org\/10.1016\/j.ctim.2019.102211 (2019).","journal-title":"Complement. Ther. Med."},{"key":"72918_CR28","doi-asserted-by":"publisher","first-page":"145966","DOI":"10.1016\/j.gene.2021.145966","volume":"808","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner. Gene. 808, 145966. https:\/\/doi.org\/10.1016\/j.gene.2021.145966 (2022).","journal-title":"Gene"},{"key":"72918_CR29","doi-asserted-by":"publisher","first-page":"104834","DOI":"10.1016\/j.ebiom.2023.104834","volume":"97","author":"L Joachim","year":"2023","unstructured":"Joachim, L. et al. The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors. EBioMedicine. 97, 104834. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104834 (2023).","journal-title":"EBioMedicine"},{"key":"72918_CR30","doi-asserted-by":"publisher","first-page":"eadh1469","DOI":"10.1126\/scitranslmed.adh1469","volume":"15","author":"C Farias Amorim","year":"2023","unstructured":"Farias Amorim, C. et al. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity. Sci. Transl Med.15, eadh1469. https:\/\/doi.org\/10.1126\/scitranslmed.adh1469 (2023).","journal-title":"Sci. Transl Med."},{"key":"72918_CR31","doi-asserted-by":"publisher","first-page":"101221","DOI":"10.1016\/j.mam.2023.101221","volume":"94","author":"L Huang","year":"2023","unstructured":"Huang, L. et al. The role of the microbiota in glaucoma. Mol. Aspects Med.94, 101221. https:\/\/doi.org\/10.1016\/j.mam.2023.101221 (2023).","journal-title":"Mol. Aspects Med."},{"key":"72918_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science. https:\/\/doi.org\/10.1126\/science.abc4552 (2021).","journal-title":"Science"},{"key":"72918_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccell.2019.11.004","volume":"36","author":"F McAllister","year":"2019","unstructured":"McAllister, F., Khan, M. A. W., Helmink, B. & Wargo, J. A. The tumor microbiome in pancreatic cancer: Bacteria and beyond. Cancer Cell36, 577\u2013579 (2019).","journal-title":"Cancer Cell"},{"key":"72918_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41585-022-00647-5","volume":"19","author":"AW Miller","year":"2022","unstructured":"Miller, A. W. et al. Mechanisms of the intestinal and urinary microbiome in kidney stone disease. Nat. Rev. Urol.19, 695\u2013707. https:\/\/doi.org\/10.1038\/s41585-022-00647-5 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"72918_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of bladder Cancer in 2023: A systematic review of risk factors. Eur. Urol.84, 176\u2013190. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.029 (2023).","journal-title":"Eur. Urol."},{"key":"72918_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chom.2020.12.001","volume":"29","author":"AB Dohlman","year":"2021","unstructured":"Dohlman, A. B. et al. The cancer microbiome atlas: A pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe 29, 281\u2013298 e285 (2021). https:\/\/doi.org\/10.1016\/j.chom.2020.12.001","journal-title":"Cell Host Microbe"},{"key":"72918_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 579, 567\u2013574. https:\/\/doi.org\/10.1038\/s41586-020-2095-1 (2020).","journal-title":"Nature"},{"key":"72918_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupret","year":"2023","unstructured":"Roupret, M. et al. European Association of Urology Guidelines on Upper urinary tract urothelial carcinoma: 2023 update. Eur. Urol.84, 49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013 (2023).","journal-title":"Eur. Urol."},{"key":"72918_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.imlet.2021.02.007","volume":"232","author":"M Van der Merwe","year":"2021","unstructured":"Van der Merwe, M., Van Niekerk, G., Botha, A. & Engelbrecht, A. M. The onco-immunological implications of Fusobacterium nucleatum in breast cancer. Immunol. Lett.232, 60\u201366. https:\/\/doi.org\/10.1016\/j.imlet.2021.02.007 (2021).","journal-title":"Immunol. Lett."},{"key":"72918_CR40","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1002\/ctm2.1331","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery. Clin. Transl Med.13, e1331. https:\/\/doi.org\/10.1002\/ctm2.1331 (2023).","journal-title":"Clin. Transl Med."},{"key":"72918_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","volume":"12","author":"A Wong-Rolle","year":"2021","unstructured":"Wong-Rolle, A., Wei, H. K., Zhao, C. & Jin, C. Unexpected guests in the tumor microenvironment: Microbiome in cancer. Protein Cell.12, 426\u2013435. https:\/\/doi.org\/10.1007\/s13238-020-00813-8 (2021).","journal-title":"Protein Cell."},{"key":"72918_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00831-8","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma. Cell. Oncol. (Dordr.). https:\/\/doi.org\/10.1007\/s13402-023-00831-8 (2023).","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"72918_CR43","doi-asserted-by":"publisher","first-page":"849756","DOI":"10.3389\/fbioe.2022.849756","volume":"10","author":"XY Li","year":"2022","unstructured":"Li, X. Y. et al. m7G methylation-related genes as biomarkers for predicting overall survival outcomes for hepatocellular carcinoma. Front. Bioeng. Biotechnol.10, 849756. https:\/\/doi.org\/10.3389\/fbioe.2022.849756 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"72918_CR44","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.1038\/s41598-022-20566-0","volume":"12","author":"J Zou","year":"2022","unstructured":"Zou, J. et al. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma. Sci. Rep.12, 16773. https:\/\/doi.org\/10.1038\/s41598-022-20566-0 (2022).","journal-title":"Sci. Rep."},{"key":"72918_CR45","doi-asserted-by":"publisher","first-page":"16285","DOI":"10.1038\/s41598-022-20858-5","volume":"12","author":"Z Lin","year":"2022","unstructured":"Lin, Z. et al. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas. Sci. Rep.12, 16285. https:\/\/doi.org\/10.1038\/s41598-022-20858-5 (2022).","journal-title":"Sci. Rep."},{"key":"72918_CR46","doi-asserted-by":"publisher","first-page":"18813","DOI":"10.1038\/s41598-022-22879-6","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis. Sci. Rep.12, 18813. https:\/\/doi.org\/10.1038\/s41598-022-22879-6 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72918-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:16:23Z","timestamp":1727432183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72918-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72918"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72918-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22198"}}